Delivery Order SPE2DB24D2003-SPE2DB24FXFR7

Award Date 7/19/24
Potential Completion Date 7/22/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of NovLog 100 unit/mL FlexPen 3mL insulin pens to the Defense Logistics Agency (DLA). The $1,056.60 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 2, 2024, with a completion date of December 3, 2024. The contract is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,815.98 firm fixed-price delivery order contract covers the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Novolog 100 Unit/mL FlexPen 3mL insulin products. The $1,810.80 fixed-price delivery order has a completion date of September 27, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as the primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,473.04 firm fixed price delivery order is for the supply of Novolin N 100 Unit/mL Flexpen 3mL, a prescription insulin product. The contract has an ultimate completion date of May 17, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, valued up to $999,999,999.00 through...
The federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,758.27 firm fixed-price delivery order is for the supply of NOVOLIN N 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. This award is under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,356.48 Firm Fixed Price Delivery Order contract covers the supply of NovoPen 100 unit/mL FlexPen 3mL insulin pens. The award has a completion date of February 8, 2024 and was issued on February 7, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,778.12 firm fixed-price delivery order is for the supply of Novolin N 100 unit/ml Flexpen 3ml, a diabetes management medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,276.06 firm-fixed-price delivery order is for the supply of INPEN (NOVOLOG or FIASP) insulin pens, with an ultimate completion date of October 18, 2024. The contract is not set-aside and represents a child award under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NovologTM 100 unit/mL FlexPen 3mL insulin pens. The contract has a ceiling value of $4,099.08 and is structured as a delivery order with a firm fixed-price pricing type. It does not have a set-aside designation. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,999.40, is for the delivery of Novolin N 100 Unit/mL Flexpen 3mL, a type of insulin product. The contract has an ultimate completion date of January 31, 2024, and is a Firm Fixed Price Delivery Order. The contract was awarded on January 30, 2024, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
  • SPE2DB24D2003
    Indefinite Delivery Contract
  • SPE2DB24D2003-SPE2DB24FXFR7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The $1,048.70 firm-fixed-price delivery order is for the supply of NovoCare 100 unit/mL FlexPen 3mL insulin devices. The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract does not have a set-aside designation. The contract was awarded on July 19, 2024, with a completion date of July 22, 2024.

Generated 10/18/24, 9:08 AM